The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa): Tolerability and geriatric asssessment (GA) results.
 
Jason Zittel
No Relationships to Disclose
 
Chunkit Fung
Consulting or Advisory Role - Exelixis; Novartis; Novartis
Research Funding - Astellas Pharma (Inst)
 
Dilip Sankar Babu
No Relationships to Disclose
 
Elizabeth A. Guancial
Honoraria - UroToday
Consulting or Advisory Role - Genentech/Roche; Taris BioMedical
Speakers' Bureau - Genentech/Roche
 
Deepak M. Sahasrabudhe
Travel, Accommodations, Expenses - Axon Communications
 
Kathryn A. Bylow
No Relationships to Disclose
 
John D. Burfeind
Stock and Other Ownership Interests - MedicaLogic
Patents, Royalties, Other Intellectual Property - I have a one third interest in IP related to clinical trial management software developed by Medicalogic.io.
 
Kaylinn Musto
Speakers' Bureau - Exelixis
Travel, Accommodations, Expenses - Pfizer
 
Bokai Wang
No Relationships to Disclose
 
Amita Patil
No Relationships to Disclose
 
Edward M. Messing
No Relationships to Disclose
 
Supriya Gupta Mohile
Consulting or Advisory Role - Seagen
 
Deepak Kilari
Consulting or Advisory Role - Exelixis; Pfizer
Research Funding - Astellas Pharma (Inst)